FOR FURTHER INFORMATION ...

FOR FURTHER INFORMATION ... (The Scientist, Vol:4, #21, pg.12, October 29, 1990) (Copyright, The Scientist, Inc.) ---------- Following is information on how to contact some of the organizations mentioned in the two stories on the Decade of the Brain in this issue. The groups listed here represent only a few of the scores of voluntary health agencies devoted to the study of neurological disorders. National Alliance for the Mentally Ill 2101 Wilson Blvd, Suite 302 Arlington, Va.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

----------

Following is information on how to contact some of the organizations mentioned in the two stories on the Decade of the Brain in this issue. The groups listed here represent only a few of the scores of voluntary health agencies devoted to the study of neurological disorders.

National Alliance for the Mentally Ill 2101 Wilson Blvd, Suite 302 Arlington, Va. 22201 (703) 524-7600

National Coalition for Research in Neurological and Communicative Disorders Suite 310 3050 K Street, N.W. Washington, D.C. 20007 (202) 293-5453 (202) 293-3204

National Foundation for Brain Research Suite 310 3050 K St., N.W. Washington, D.C. 20007 (202) 293-5453 (202) 293-3204

National Organization for Rare Disorders P.O. Box 8923 New Fairfield, Conn. 06182 (203) 746-6518 (800) 447-6673

National Stroke Association 300 East Hampden Ave. Suite 240 Englewood, Colo. 80110-2622 (303) 762-9922

Parkinson's Disease Foundation William Black Medical Research Building 650 W. 168th St. New York, N.Y. 10032-9982 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies